Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
15.52
-0.35 (-2.21%)
Nov 21, 2024, 2:54 PM EST - Market open

Tyra Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-83.74-69.13-55.33-26.29-9.34-4.07
Depreciation & Amortization
0.470.350.30.140.050.01
Loss (Gain) From Sale of Assets
00000-
Loss (Gain) From Sale of Investments
-5.95-1.25----
Stock-Based Compensation
20.2913.5310.592.890.44-
Other Operating Activities
----0.020.93
Change in Accounts Payable
2.129.372.361.491.020.46
Change in Other Net Operating Assets
3.09-3.01-8.2-1.970.050.04
Operating Cash Flow
-63.72-50.14-50.29-23.75-7.76-2.62
Capital Expenditures
-1.26-0.77-0.56-0.66-0.31-0.02
Sale of Property, Plant & Equipment
---0.02--
Investment in Securities
-248.54-143.84----
Investing Cash Flow
-249.8-144.61-0.56-0.65-0.31-0.02
Long-Term Debt Repaid
----0.01-0.02-0.01
Net Debt Issued (Repaid)
----0.01-0.02-0.01
Issuance of Common Stock
202.181.540.63181.730.140.17
Financing Cash Flow
201.761.540.63311.3523.430.16
Net Cash Flow
-111.76-193.21-50.21286.9615.36-2.48
Free Cash Flow
-64.98-50.91-50.84-24.41-8.08-2.64
Free Cash Flow Per Share
-1.22-1.19-1.21-1.77-5.24-1.00
Cash Interest Paid
---1.2400
Levered Free Cash Flow
-37.57-29.49-28.56-14.18-8.98-
Unlevered Free Cash Flow
-37.57-29.49-28.56-14.18-8.97-
Change in Net Working Capital
-5.47-7.372.050.123.34-
Source: S&P Capital IQ. Standard template. Financial Sources.